knowledge -WSS

knowledge

author：comprehensive 2025-10-01 18:33:45 - browse：2

Boston Globe

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as allergy season is about to start.

In a move unusual for such a widely used drug, GlaxoSmithKline discontinued Flovent HFA, the brand name of its corticosteroid treatment fluticasone propionate, at the end of December. Critics, including Massachusetts Senator Elizabeth Warren, say the decision helps the company avoid new Medicaid penalties going into effect this year for medications with price increases that outpace inflation.

“It was all very confusing, and we were left scrambling, trying to find out what we could do,” said Simone Fung, whose 5-year-old son, David, endured worse asthma symptoms over the past two months as the Cambridge family navigated confusing insurance policies and shortages of alternative medications to find a replacement for Flovent.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Why do we get seasonal allergies?

WSS

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Ukrainian soldiers say they owe lives to US

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Supreme Court strikes down Biden student loan forgiveness program

Why do we get seasonal allergies?

Biden administration opens offers in Medicare drug price negotiations

Wikipedia

knowledge

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Cybersecurity threat forces Lurie Children's to take systems offline

In age of alternative facts, a scholarly course on calling out crap

Tuskegee Airman Raymond Cassagnol dies at 102

United colonoscopy coverage change 'may cost lives,' doctors say

Even great ERs can’t make up for American health disparities

Novavax promises a turnaround & Lilly roils the obesity market

Apple Vision Pro: A first look at health apps on the new VR headset

As demand for Covid shots wanes, Moderna seeks its next success

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

leisure time

Medicare drug price negotiation’s day in court

Illumina to lay off 10% of research and development team

Medical experts exlpore how to eliminate bias in clinical algorithms

The real point of Kenneth Smith’s execution by nitrogen gas

Supreme Court rules employers must be more accommodating of religious observance

Even great ERs can’t make up for American health disparities

focus

focus

leisure time

explore